- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06031324
The Role of Lung Ultrasonography Score in Predicting Prognosis in Term and Late Preterm Newborns With Postnatal Respiratory Distress (TeLaPLUS)
July 12, 2024 updated by: Bayram Ali DORUM, Bursa City Hospital
Respiratory distress in term and late preterm infants in the first hour after birth is a prevalent condition.
This situation may occur due to different reasons such as minimal respiratory stress, transient tachypnea of newborn, respiratory distress syndrome, and congenital pneumonia.
It can be not easy to distinguish this in the first hours.
This study aimed to investigate the place of the lung ultrasonography score in the prognosis of these patients.
Study Overview
Status
Recruiting
Study Type
Observational
Enrollment (Estimated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Bayram Ali Dorum
- Phone Number: +905337078398
- Email: bayramalidorum@gmail.com
Study Contact Backup
- Name: Ayten Erdoğan Ordu
- Email: aytenli21@hotmail.com
Study Locations
-
-
-
Bursa, Turkey
- Recruiting
- Bursa City Hospital
-
Contact:
- Bayram Ali Dorum
- Email: bayramalidorum@gmail.com
-
Sub-Investigator:
- Ayten Erdogan Ordu
-
Sub-Investigator:
- Bensu Zadeoglu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
N/A
Sampling Method
Non-Probability Sample
Study Population
Term and late-preterm premature newborns with respiratory distress symptoms in the first 30 minutes after birth
Description
Inclusion Criteria:
- Having symptoms of respiratory distress that begin soon after birth,
- > 34 gestational age,
- >1900 gr birth weight,
- Family consent
Exclusion Criteria:
- Congenital anomaly
- Chromosomal anomaly
- Hydrops fetalis
- Congenital heart disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Enrollment of a targeted number of patients
Time Frame: 4 months
|
4 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 11, 2023
Primary Completion (Estimated)
December 31, 2024
Study Completion (Estimated)
February 28, 2025
Study Registration Dates
First Submitted
September 2, 2023
First Submitted That Met QC Criteria
September 2, 2023
First Posted (Actual)
September 11, 2023
Study Record Updates
Last Update Posted (Actual)
July 15, 2024
Last Update Submitted That Met QC Criteria
July 12, 2024
Last Verified
July 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- BCH-2023-14/2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Respiratory Distress Syndrome
-
Rise Therapeutics LLCNot yet recruitingAcute Respiratory Distress Syndrome
-
PT. Prodia Stem Cell IndonesiaRumah Sakit Pusat Angkatan Darat Gatot SoebrotoRecruitingAcute Respiratory Distress SyndromeIndonesia
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...Not yet recruiting
-
Changchun Tuohua Pharmaceutical Co., Ltd.RecruitingAcute Respiratory Distress SyndromeChina
-
Southeast University, ChinaRecruitingAcute Respiratory Distress SyndromeChina
-
Southeast University, ChinaRecruitingAcute Respiratory Distress SyndromeChina
-
Ramos Mejía HospitalUniversidad de la RepublicaNot yet recruitingRespiratory Distress Syndrome (RDS)
-
Vastra Gotaland RegionGöteborg UniversityNot yet recruitingRespiratory Distress Syndrome in Premature Infant | Respiratory Distress Syndrome of Newborn | Respiratory Distress Syndrome (& [Hyaline Membrane Disease]) | Respiratory Distress Syndrome (RDS) | Respiratory Distress Syndrome (Neonatal)
-
Fayoum UniversityNot yet recruitingAcute Respiratory Distress Syndrome (ARDS)
-
Assistance Publique - Hôpitaux de ParisNot yet recruitingAcute Respiratory Distress Syndrome (ARDS)